Immunopharmacology

KININ '96 DURBAN - 20-25 October 1996
pp. 103-104(2)
Authors: Bhoola K.; Naidoo Y.; Fritz H.

Award ceremony of the E.K. Frey-E. Werle Foundation of the Henning L. Voigt Family
pp. 105-108(4)
Author: Muller-Esterl W.

Search for autoantibodies to the human bradykinin B2 receptor
pp. 109-113(5)
Authors: Micke P.; Blaukat A.; Muller-Esterl W.

Inhibition of B2 receptor internalization delays its dephosphorylation
pp. 115-119(5)
Authors: Blaukat A.; Muller-Esterl W.

Immunolocalization of bradykinin receptors on human synovial tissue
pp. 121-125(5)
Authors: Cassim B.; Naidoo S.; Ramsaroop R.; Bhoola K.D.

Localization of the bradykinin B2 receptor in uterus, bladder and Madin-Darby canine kidney cells
pp. 127-133(7)
Authors: Figueroa C.D.; Novoa U.; Valdes G.; Corthorn J.; Muller-Esterl W.

Evidence for bradykinin B2-receptors on cultured human decidua cells
pp. 135-141(7)
Authors: Rehbock J.; Chondromatidou A.; Miska K.; Buchinger P.; Hermann A.

B1 and B2 kinin receptors in various species
pp. 143-147(5)
Authors: Regoli D.; Rizzi A.; Calo G.; Nsa Allogho S.; Gobeil F.

Expression of bradykinin B1 receptors in colonic epithelia
pp. 149-152(4)
Authors: Cuthbert A.W.; Teather S.

Kinin receptors in human vascular tissue: their role in atheromatous disease
pp. 153-160(8)
Authors: Raidoo D.M.; Ramsaroop R.; Naidoo S.; Muller-Esterl W.; Bhoola K.D.

Kinin receptor status in normal and inflammed gastric mucosa
pp. 161-165(5)
Authors: Bhoola R.; Ramsaroop R.; Naidoo S.; Muller-Esterl W.; Bhoola K.D.

Potent, long-acting, orally-active bradykinin antagonists for a wide range of applications
pp. 167-172(6)
Authors: Stewart J.M.; Gera L.; Chan D.C.; Whalley E.T.; Hanson W.L.; Zuzack J.S.

Tachyphylaxis of the B1 kinin receptor in porcine endotoxin shock
pp. 173-177(5)
Authors: Eich-Rathfelder S.; Whalley E.T.; Fautz M.; Hohenbleicher F.; Fritz H.; Siebeck M.

Effect of bradykinin B2-receptor antagonism on post-ischemic coronary reperfusion
pp. 179-183(5)
Authors: Neuhof C.; Soeffker G.; Cernaianu G.; Dapper F.; Tillmanns H.; Neuhof H.

Possible protective effects of kinins and converting enzyme inhibitors in cardiovascular tissues
pp. 185-191(7)
Authors: Nolly H.; Miatello R.; Damiani M.T.; Abate C.D.

Physical and biological significance of peptide sequences mediating the interaction between high molecular weight kininogen and plasma prekallikrein
pp. 193-200(8)
Authors: Colman R.W.; Lin Y.; Yan W.; McCrae K.R.; Shenoy S.S.; Harris R.B.

Binding of activation of kinin-forming proteins on vascular endothelial cells
pp. 201-207(7)
Authors: Kaplan A.P.; Joseph K.; Shibayama Y.

Generation of kinins in synovial fluid from patients with arthropathy
pp. 209-216(8)
Authors: Bond A.P.; Lemon M.; Dieppe P.A.; Bhoola K.D.

Tissue kallikrein and the bradykinin B2 receptor are expressed in endometrial and prostate cancers
pp. 217-220(4)
Authors: Clements J.; Mukhtar A.

Expression of human tissue kallikrein in rat salivary glands and its secretion into circulation following adenovirus-mediated gene transfer
pp. 221-227(7)
Authors: Wang C.; Chao C.; Chao L.; Chao J.

Kallikrein gene therapy: a new strategy for hypertensive diseases
pp. 229-236(8)
Authors: Chao J.; Chao L.

Role of the renal kallikrein-kinin system in the development of hypertension
pp. 237-242(6)
Authors: Katori M.; Majima M.

Changes in urinary tissue kallikrein excretion in black African women with hypertensive disorders of pregnancy
pp. 243-247(5)
Authors: Khedun S.M.; Naicker T.; Moodley J.; Naidoo S.; Bhoola K.D.

Localisation of tissue kallikrein in the kidney of black African women with early onset pre-eclampsia: a pilot study
pp. 249-254(6)
Authors: Naicker T.; Khedun S.M.; Moodley J.; Bhoola K.D.

Tissue kallikrein in transplant kidney
pp. 255-261(7)
Authors: Ramsaroop R.; Naicker S.; Naicker T.; Naidoo S.; Bhoola K.D.

The evaluation of tissue kallikrein in Helicobacter pylori-associated gastric ulcer disease
pp. 263-269(7)
Authors: Naidoo S.; Ramsaroop R.; Bhoola R.; Bhoola K.D.

Proteolytic release of membrane proteins: studies on a membrane-protein-solubilizing activity in CHO cells
pp. 271-278(8)
Authors: Ehlers M.R.W.; Schwager S.L.U.; Chubb A.J.; Scholle R.R.; Brandt W.F.; Riordan J.F.

Protein C inhibitor (PCI) and heparin cofactor II (HCII): possible alternative roles of these heparin-binding serpins outside the hemostatic system
pp. 279-284(6)
Authors: Geiger M.; Krebs M.; Jerabek I.; Binder B.R.

Characterization of a multicatalytic proteinase complex (20S proteasome) from Trypanosoma brucei brucei
pp. 285-293(9)
Authors: Lomo P.O.; Coetzer T.H.T.; Lonsdale-Eccles J.D.

Production of anti-peptide antibodies against trypanopain-Tb from Trypanosoma brucei brucei: effects of antibodies on enzyme activity against Z-Phe-Arg-AMC
pp. 295-303(9)
Authors: Troeberg L.; Pike R.N.; Lonsdale-Eccles J.D.; Coetzer T.H.T.

Anti-cathepsin D chicken IgY antibodies: characterisation, cross-species reactivity and application in immunogold labelling of human splenic neutrophils and fibroblasts
pp. 305-311(7)
Authors: Fortgens P.H.; Dennison C.; Elliott E.